Chlorhexidine Compared with Povidone–Iodine in Intravitreal Injection: A Systematic Review and Meta-Analysis
- 1 April 2025
- journal article
- research article
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 41 (3) , 162-168
Abstract
Introduction: Povidone-iodine (PI) is the standard antiseptic for intravitreal injections (IVIs), while chlorhexidine (CHX) is a potential alternative. The efficacy of PI versus CHX in preventing endophthalmitis remains debated, with studies showing mixed results. Objective: To compare the effectiveness of using PI compared with CHX in IVI procedures regarding endophthalmitis rates, culture-positive endophthalmitis rates, and changes in visual acuity. Methods: A systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. We searched the PubMed, EMBASE, Cochrane, and Web of Science databases for studies using PI compared with CHX in the IVI procedure. Statistical analysis was done using R software. Results: Four studies encompassing 453,340 eyes were included. The pooled results showed no statistical differences in endophthalmitis rates [odds ratio (OR): 1.26; 95% confidence interval (CI): 0.53-3.00]. In those who received the CHX group, there was no decrease in the rates of culture-positive endophthalmitis (OR: 2.04; 95% CI: 0.76-5.47), and the pooled results revealed no statistical differences in the mean change in visual acuity between the CHX and PI groups at final follow-up [mean difference: -0.02; 95% CI: -0.40 to 0.36]. Significant heterogeneity was identified in the post-procedure endophthalmitis rate and culture-positive endophthalmitis rate. Conclusions: Despite finding a trend toward higher rates of endophthalmitis with CHX, there are no statistical differences in using PI compared with CHX. However, our results are limited due to high heterogeneity. PI remains the gold standard, and a widespread shift to CHX cannot be justified based on the findings of this analysis.Keywords
This publication has 25 references indexed in Scilit:
- Rates of endophthalmitis before and after transition from povidone-iodine to aqueous chlorhexidine asepsis for intravitreal injectionCanadian Journal of Ophthalmology, 2024
- Doctor I Have an Iodine AllergyOphthalmology and Therapy, 2022
- Aqueous Chlorhexidine Compared with Povidone-Iodine as Ocular Antisepsis before Intravitreal Injection: A Randomized Clinical TrialOphthalmology Retina, 2021
- Patient-Reported Complications after Intravitreal Injection and Their Predictive FactorsOphthalmology Retina, 2021
- Certification and Credentials of Intravitreal Injection Proceduralists in the United StatesOphthalmology Retina, 2021
- Minimizing the Risk of Endophthalmitis after InjectionOphthalmology Retina, 2019
- Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor InhibitorsOphthalmology, 2018
- Stimuli sensitive ocular drug delivery systems2018
- Ocular Complications After Anti–Vascular Endothelial Growth Factor Therapy in Medicare Patients With Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 2011
- Efficacy of concurrent application of chlorhexidine gluconate and povidone iodine against six nosocomial pathogensAmerican Journal of Infection Control, 2010